upper respiratory tract infection

File:Cold symptoms cdc.jpg

In uncomplicated colds, coughing and nasal discharge may persist for 14 days or more even after other symptoms have resolved.

Acute URTIs include rhinitis, pharyngitis/tonsillitis, and laryngitis often referred to as a common cold, and their complications: sinusitis, ear infection, and sometimes bronchitis (though bronchi are generally classified as part of the lower respiratory tract.) Symptoms of URTIs commonly include cough, sore throat, runny nose, nasal congestion, headache, low-grade fever, facial pressure, and sneezing.{{cite book| vauthors=Dasaraju PV, Liu C| chapter-url=https://www.ncbi.nlm.nih.gov/books/NBK8142/| chapter=Chapter 93: Infections of the Respiratory System| title=Medical Microbiology| edition=4th| via=National Center for Biotechnology Information, U.S. National Library of Medicine| year=1996| publisher=University of Texas Medical Branch at Galveston| pmid=21413304| isbn=978-0-9631172-1-2| access-date=10 July 2021| veditors=Baron S| archive-date=26 October 2022| archive-url=https://web.archive.org/web/20221026132511/https://www.ncbi.nlm.nih.gov/books/NBK8142/| url-status=live}}

Symptoms of rhinovirus in children usually begin 1–3 days after exposure. The illness usually lasts 7–10 more days.

Color or consistency changes in mucous discharge to yellow, thick, or green are the natural course of viral URTI and not an indication for antibiotics.

Group A beta-hemolytic streptococcal pharyngitis/tonsillitis (strep throat) typically presents with a sudden onset of sore throat, pain with swallowing, and fever. Strep throat does not usually cause a runny nose, voice changes, or cough.{{citation needed|date=November 2020}}

Pain and pressure of the ear caused by a middle-ear infection (otitis media) and the reddening of the eye caused by viral conjunctivitis{{cite web

| url=https://www.lecturio.com/concepts/conjunctivitis/

| title=Conjunctivitis

| website=The Lecturio Medical Concept Library

| date=23 July 2020

| access-date=10 July 2021

| archive-date=10 July 2021

| archive-url=https://web.archive.org/web/20210710103729/https://www.lecturio.com/concepts/conjunctivitis/

| url-status=live

}} are often associated with URTIs.

In terms of pathophysiology, rhinovirus infection resembles the immune response. The viruses do not cause damage to the cells of the upper respiratory tract, but rather cause changes in the tight junctions of epithelial cells. This allows the virus to gain access to tissues under the epithelial cells and initiate the innate and adaptive immune responses.{{rp|27}}

Up to 15% of acute pharyngitis cases may be caused by bacteria, most commonly Streptococcus pyogenes, a group A streptococcus in streptococcal pharyngitis ("strep throat").{{cite journal | vauthors = Bisno AL | title = Acute pharyngitis | journal = The New England Journal of Medicine | volume = 344 | issue = 3 | pages = 205–11 | date = January 2001 | pmid = 11172144 | doi = 10.1056/nejm200101183440308 }} Other bacterial causes are Streptococcus pneumoniae, Haemophilus influenzae, Corynebacterium diphtheriae, Bordetella pertussis, and Bacillus anthracis{{citation needed|date=December 2016}}.

Sexually transmitted infections have emerged as causes of oral and pharyngeal infections.{{cite web | title = Human papillomavirus (HPV) and Oropharyngeal Cancer, Sexually Transmitted Diseases | publisher = Centers for Disease Control and Prevention | url = https://www.cdc.gov/std/hpv/STDFact-HPVandOropharyngealCancer.htm | date = 2016-11-04 | access-date = 2016-12-19 | url-status = live | archive-url = https://web.archive.org/web/20161216053009/https://www.cdc.gov/std/hpv/stdfact-hpvandoropharyngealcancer.htm | archive-date = 16 December 2016 }}

A URTI may be classified by the area inflamed.

Rhinitis affects the nasal mucosa, while rhinosinusitis or sinusitis affects the nose and paranasal sinuses, including frontal, ethmoid, maxillary, and sphenoid sinuses. Nasopharyngitis (rhinopharyngitis or the common cold) affects the nares, pharynx, hypopharynx, uvula, and tonsils generally. Without involving the nose, pharyngitis inflames the pharynx, hypopharynx, uvula, and tonsils. Similarly, epiglottitis (supraglottitis) inflames the superior portion of the larynx and supraglottic area; laryngitis is in the larynx; laryngotracheitis is in the larynx, trachea, and subglottic area; and tracheitis is in the trachea and subglottic area.{{citation needed|date=December 2016}}

Vaccination against influenza viruses, adenoviruses, measles, rubella, Streptococcus pneumoniae, Haemophilus influenzae, diphtheria, Bacillus anthracis, and Bordetella pertussis may prevent them from infecting the URT or reduce the severity of the infection.{{citation needed|date=December 2016}}

[[File:Upper respiratory infections world map-Deaths per million persons-WHO2012.svg|thumb|upright=1.4|Upper respiratory infections deaths per million persons in 2012

{{Div col|small=yes|colwidth=10em}}{{legend|#ffff20|0}}{{legend|#e06815|1}}{{legend|#d85010|2}}{{legend|#d02010|3–29}}{{div col end}}

]]

Treatment comprises symptomatic support usually via analgesics for headache, sore throat, and muscle aches.{{cite web|title=Common Cold: Treatments and Drugs|publisher=Mayo Clinic|url=http://www.mayoclinic.com/health/common-cold/DS00056/DSECTION=treatments-and-drugs|access-date=9 January 2010|url-status=live|archive-url=https://web.archive.org/web/20100212105512/http://www.mayoclinic.com/health/common-cold/DS00056/DSECTION=treatments%2Dand%2Ddrugs|archive-date=12 February 2010}} Moderate exercise in sedentary subjects with a naturally acquired URTI probably does not alter the overall severity and duration of the illness.{{cite journal | vauthors = Weidner T, Schurr T | title = Effect of exercise on upper respiratory tract infection in sedentary subjects | journal = British Journal of Sports Medicine | volume = 37 | issue = 4 | pages = 304–6 | date = August 2003 | pmid = 12893713 | pmc = 1724675 | doi = 10.1136/bjsm.37.4.304 }} No randomized trials have been conducted to ascertain benefits of increasing fluid intake.{{cite journal | vauthors = Guppy MP, Mickan SM, Del Mar CB | title = "Drink plenty of fluids": a systematic review of evidence for this recommendation in acute respiratory infections | journal = The BMJ | volume = 328 | issue = 7438 | pages = 499–500 | date = February 2004 | pmid = 14988184 | pmc = 351843 | doi = 10.1136/bmj.38028.627593.BE }}

Prescribing antibiotics for laryngitis is not a suggested practice.{{cite journal | vauthors = Reveiz L, Cardona AF | title = Antibiotics for acute laryngitis in adults | journal = The Cochrane Database of Systematic Reviews | issue = 5 | pages = CD004783 | date = May 2015 | volume = 2015 | pmid = 26002823 | pmc = 6486127 | doi = 10.1002/14651858.CD004783.pub5 }} The antibiotics penicillin V and erythromycin are not effective for treating acute laryngitis. Erythromycin may improve voice disturbances after a week and cough after 2 weeks, but any modest subjective benefit is not greater than the adverse effects, cost, and the risk of bacteria developing resistance to the antibiotics. Health authorities have been strongly encouraging physicians to decrease the prescribing of antibiotics to treat common URTIs because antibiotic usage does not significantly reduce recovery time for these viral illnesses. A 2017 systematic review found three interventions which were probably effective in reducing antibiotic use for acute respiratory infections: C-reactive protein testing, procalcitonin-guided management, and shared decision-making between physicians and patients.{{cite journal | vauthors = Tonkin-Crine SK, Tan PS, van Hecke O, Wang K, Roberts NW, McCullough A, Hansen MP, Butler CC, Del Mar CB | display-authors = 6 | title = Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews | journal = The Cochrane Database of Systematic Reviews | volume = 2019 | pages = CD012252 | date = September 2017 | issue = 9 | pmid = 28881002 | pmc = 6483738 | doi = 10.1002/14651858.CD012252.pub2 }} The use of narrow-spectrum antibiotics has been shown to be just as effective as broad-spectrum alternatives for children with acute bacterial URTIs, and has a lower risk of side effects in children.{{cite journal | vauthors = Gerber JS, Ross RK, Bryan M, Localio AR, Szymczak JE, Wasserman R, Barkman D, Odeniyi F, Conaboy K, Bell L, Zaoutis TE, Fiks AG | display-authors = 6 | title = Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections | journal = JAMA | volume = 318 | issue = 23 | pages = 2325–2336 | date = December 2017 | pmid = 29260224 | pmc = 5820700 | doi = 10.1001/jama.2017.18715 }} Decreased antibiotic usage may also help prevent drug-resistant bacteria. Some have advocated a delayed antibiotic approach to treating URTIs, which seeks to reduce the consumption of antibiotics while attempting to maintain patient satisfaction. A Cochrane review of 11 studies and 3,555 participants explored antibiotics for respiratory tract infections. It compared delaying antibiotic treatment to either starting them immediately or to no antibiotics. Outcomes were mixed depending on the respiratory tract infection; symptoms of acute otitis media and sore throat were modestly improved with immediate antibiotics with minimal difference in complication rate. Antibiotic usage was reduced when antibiotics were only used for ongoing symptoms and maintained patient satisfaction at 86%.{{cite journal | vauthors = Spurling GK, Dooley L, Clark J, Askew DA | title = Immediate versus delayed versus no antibiotics for respiratory infections | journal = The Cochrane Database of Systematic Reviews | volume = 2023 | issue = 10 | pages = CD004417 | date = October 2023 | pmid = 37791590 | pmc = 10548498 | doi = 10.1002/14651858.CD004417.pub6 }} In a trial involving 432 children with a URTI, amoxicillin was no more effective than placebo, even for children with more severe symptoms such as fever or shortness of breath.{{cite journal | vauthors = Little P, Francis NA, Stuart B, O'Reilly G, Thompson N, Becque T, Hay AD, Wang K, Sharland M, Harnden A, Yao G, Raftery J, Zhu S, Little J, Hookham C, Rowley K, Euden J, Harman K, Coenen S, Read RC, Woods C, Butler CC, Faust SN, Leydon G, Wan M, Hood K, Whitehurst J, Richards-Hall S, Smith P, Thomas M, Moore M, Verheij T | display-authors = 6 | title = Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT | journal = Health Technology Assessment | volume = 27 | issue = 9 | pages = 1–90 | date = June 2023 | pmid = 37436003 | pmc = 10350739 | doi = 10.3310/DGBV3199 }}{{cite journal |date=27 November 2023 |title=Antibiotics make little difference to children's chest infections |url=https://evidence.nihr.ac.uk/alert/antibiotics-make-little-difference-to-childrens-chest-infections/ |journal=NIHR Evidence |publisher=National Institute for Health and Care Research (NIHR) |location=UK |doi=10.3310/nihrevidence_60506 |access-date=4 December 2023 |archive-date=18 June 2024 |archive-url=https://web.archive.org/web/20240618203530/https://evidence.nihr.ac.uk/alert/antibiotics-make-little-difference-to-childrens-chest-infections/ |url-status=live }}

For sinusitis while at the same time discouraging overuse of antibiotics the CDC recommends:

• Target likely organisms with first-line medications: amoxicillin, amoxicillin/clavulanate
• Use the shortest effective course; should see improvement in 2–3 days. Continue treatment for 7 days after symptoms improve or resolve (usually a 10–14 day course).
• Consider imaging studies in recurrent or unclear cases; some sinus involvement is frequent early in the course of uncomplicated viral URI

No good evidence exists for or against the effectiveness of over-the-counter cough medications for reducing coughing in adults or children.{{cite journal | vauthors = Smith SM, Schroeder K, Fahey T | title = Over-the-counter (OTC) medications for acute cough in children and adults in community settings | journal = The Cochrane Database of Systematic Reviews | issue = 11 | pages = CD001831 | date = November 2014 | volume = 2014 | pmid = 25420096 | doi = 10.1002/14651858.CD001831.pub5 | pmc = 7061814 }} Children under 2 years old should not be given any type of cough or cold medicine due to the potential for life-threatening side effects.{{cite web|url=https://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm263948.htm|title=Special Features – Use Caution When Giving Cough and Cold Products to Kids | author = Center for Drug Evaluation and Research |publisher=Food and Drug Administration|language=en|access-date=2017-01-23|url-status=live|archive-url=https://web.archive.org/web/20170112003546/https://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm263948.htm|archive-date=12 January 2017}} In addition, according to the American Academy of Pediatrics, the use of cough medicine to relieve cough symptoms should be avoided in children under 4 years old, and the safety is questioned for children under 6 years old.{{cite journal | vauthors = Goldsobel AB, Chipps BE | title = Cough in the pediatric population | journal = The Journal of Pediatrics | volume = 156 | issue = 3 | pages = 352–8 | date = March 2010 | pmid = 20176183 | doi = 10.1016/j.jpeds.2009.12.004 }}

File:Upper respiratory infections world map - DALY - WHO2002.svg for URTIs per 100,000 inhabitants in 2002:{{cite web |url=https://www.who.int/entity/healthinfo/statistics/bodgbddeathdalyestimates.xls |title=Mortality and Burden of Disease Estimates for WHO Member States in 2002 |format=xls |publisher=World Health Organization |year=2002 |url-status=live |archive-url=https://web.archive.org/web/20130116174540/http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls |archive-date=16 January 2013 }}{{Div col|small=yes|colwidth=10em}}

{{legend|#b3b3b3|no data}}

{{legend|#ffff65|less than 10}}

{{legend|#fff200|10–30}}

{{legend|#ffdc00|30–60}}

{{legend|#ffc600|60–90}}

{{legend|#ffb000|90–120}}

{{legend|#ff9a00|120–150}}

{{legend|#ff8400|150–180}}

{{legend|#ff6e00|180–210}}

{{legend|#ff5800|210–240}}

{{legend|#ff4200|240–270}}

{{legend|#ff2c00|270–300}}

{{legend|#cb0000|more than 300}}

{{div col end}}]]

According to a Cochrane review, a single oral dose of nasal decongestant in the common cold is modestly effective for the short-term relief of congestion in adults; however, data on the use of decongestants in children are insufficient. Therefore, decongestants are not recommended for use in children under 12 years of age with the common cold. Oral decongestants are also contraindicated in patients with hypertension, coronary artery disease, and history of bleeding strokes.{{cite book | vauthors = Tietze KJ |chapter=Disorders related to cold and allergy | veditors = Berardi RR |title=Handbook of Nonprescription Drugs |edition=14th |location=Washington, DC |publisher=American Pharmacists Association |date=2004 |oclc=56446842 |isbn=978-1-58212-050-8 |pages=239–269 }}{{cite book |chapter=Common cold | veditors = Covington TR |title=Nonprescription Drug Therapy: Guiding Patient Self-care |edition=1st |location=St Louis, MO |publisher=Facts & Comparisons |date=2002 |oclc=52895543 |isbn=978-1-57439-146-6 |pages=743–769 }}

Mucolytics such as acetylcysteine and carbocystine are widely prescribed for upper and lower respiratory tract infection without chronic broncho-pulmonary disease. However, in 2013 a Cochrane review reported their efficacy to be limited.{{cite journal | vauthors = Chalumeau M, Duijvestijn YC | title = Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease | journal = The Cochrane Database of Systematic Reviews | issue = 5 | pages = CD003124 | date = May 2013 | pmid = 23728642 | doi = 10.1002/14651858.CD003124.pub4 | pmc = 11285305 }} Acetylcysteine is considered to be safe for the children older than 2 years.

Routine supplementation with vitamin C is not justified, as it does not appear to be effective in reducing the incidence of common colds in the general population. The use of vitamin C in the inhibition and treatment of upper respiratory infections has been suggested since the initial isolation of vitamin C in the 1930s. Some evidence exists to indicate that it could be justified in persons exposed to brief periods of severe physical exercise and/or cold environments.{{cite journal | vauthors = Hemilä H, Chalker E | title = Vitamin C for preventing and treating the common cold | journal = The Cochrane Database of Systematic Reviews | issue = 1 | pages = CD000980 | date = January 2013 | volume = 2013 | pmid = 23440782 | pmc = 1160577 | doi = 10.1002/14651858.CD000980.pub4 }} Given that vitamin C supplements are inexpensive and safe, people with common colds may consider trying vitamin C supplements to assess whether they are therapeutically beneficial in their case.

Some low-quality evidence indicates the use of nasal irrigation with saline solution may alleviate symptoms in some people.{{cite journal | vauthors = King D, Mitchell B, Williams CP, Spurling GK | title = Saline nasal irrigation for acute upper respiratory tract infections | journal = The Cochrane Database of Systematic Reviews | issue = 4 | pages = CD006821 | date = April 2015 | volume = 2015 | pmid = 25892369 | doi = 10.1002/14651858.CD006821.pub3 | pmc = 9475221 | url = http://espace.library.uq.edu.au/view/UQ:201653/UQ201653_OA.pdf | access-date = 4 November 2018 | archive-date = 29 August 2021 | archive-url = https://web.archive.org/web/20210829061619/https://espace.library.uq.edu.au/data/UQ_201653/UQ201653_OA.pdf?Expires=1630217866&Key-Pair-Id=APKAJKNBJ4MJBJNC6NLQ&Signature=fvzZFSRIkQZTLEhLp~QFYol~hVWVs5Yo2o0Vw3BhGOL7U3pmZx7K1xwMdix20C-ZBOBTDrFZyWfczpiMKk7xmMWYUsYU8tEF9SRghcv~x04vWlZkkUuL3E7OHRYrkCFawyesJkkEEQO5sQxtD0LLWuoQWlT7yRRWk4ZqrLeW7OCsFY5NhBYavteJhqCqtWifH5hIamsdfCYNZnVKx4mp66bQ5L5iozTDtmriPethrPxdoRvyPvYoPscI~ayOcvCjCjdYxsooSxLtw1KPpsbBbtEACOPp35YxrEPcON9XJO04wJeqpcy9FsRhJHM1Gg1-b8p5xUSx3LRrF42Dirskaw__ | url-status = live }} Also, saline nasal sprays can be of benefit.{{Citation needed|date=January 2017}}

Children typically have two to nine viral respiratory illnesses per year. In 2013, 18.8 billion cases of URTIs were reported.{{cite journal |author=((Global Burden of Disease Study 2013 Collaborators)) | title = Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | journal = Lancet | volume = 386 | issue = 9995 | pages = 743–800 | date = August 2015 | pmid = 26063472 | pmc = 4561509 | doi = 10.1016/s0140-6736(15)60692-4 }} As of 2014, they caused about 3,000 deaths, down from 4,000 in 1990. In the United States, URTIs are the most common infectious illness in the general population, and are the leading reasons for people missing work and school.{{citation needed|date=December 2016}}

Weak evidence suggests that probiotics may be better than a placebo treatment or no treatment for preventing upper respiratory tract infections.{{cite journal | vauthors = Zhao Y, Dong BR, Hao Q | title = Probiotics for preventing acute upper respiratory tract infections | journal = The Cochrane Database of Systematic Reviews | volume = 2022 | issue = 8 | pages = CD006895 | date = August 2022 | pmid = 36001877 | pmc = 9400717 | doi = 10.1002/14651858.CD006895.pub4 }}

• Lower respiratory tract infection

{{clear right}}

{{reflist}}

{{Medical condition classification and resources

| ICD10 = {{ICD10|J|00-06||j|00}}, {{ICD10|J|30-39||j|30}}

| ICD9 = {{ICD9|465.9}}

}}

• [http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/infectious-disease/upper-respiratory-tract-infection/ Upper Respiratory Tract Infection] from Cleveland Clinic Online Medical Reference

{{Respiratory pathology}}

{{Inflammation}}

{{Common cold}}

Category:Infectious diseases

Category:Inflammations

Category:Upper respiratory tract diseases